My Account Log in

2 options

Development and approval of combination products : a regulatory perspective / edited by Evan B. Siegel.

Table of contents only Available online

View online
Holman Biotech Commons RA401.5 .D48 2008
Loading location information...

Available This item is available for access.

Log in to request item
Format:
Book
Contributor:
Siegel, Evan B.
Language:
English
Subjects (All):
Drug approval--United States.
Drug approval.
Medical instruments and apparatus.
Biological products.
United States.
Biological products--United States.
Medical instruments and apparatus--United States.
United States. Food and Drug Administration.
Drug Approval--legislation & jurisprudence.
Drug Combinations.
Device Approval--legislation & jurisprudence.
Medical Subjects:
Drug Approval--legislation & jurisprudence.
United States.
Drug Combinations.
Device Approval--legislation & jurisprudence.
Physical Description:
xii, 215 pages : illustrations ; 25 cm
Place of Publication:
Hoboken, N.J. : Wiley, [2008]
Summary:
Using a proven integrated approach to combination drug development, this book guides you step by step through all the preclinical, clinical, and manufacturing stages. Written from an FDA regulatory perspective, the book not only enables you to bring a successful combination drug product to market, it also sets forth the most efficient and effective path to FDA approval.
The book begins with an introductory chapter presenting definitions and basic regulatory principles of combination products. Next, it reviews manufacturing and controls, preclinical testing models, pharmacology, clinical testing, regulatory submissions, FDA reviews, and approvals. Among the key topics examined are: The pharmacology, safety pharmacology, and toxicology supporting human clinical trials of combination products, Approaches to clinical trial protocol design and execution, Chemical, physicochemical, and analytical aspects of manufacturing controls and validation that lead to stable components for combination products, Key sponsor/FDA meetings and negotiations essential for approval and commercialization.
Case studies involving such actual combination products as Mylotarg, Herceptin, and HercepTest help you better understand how to implement the author's practical guidelines. References at the end of each chapter enble you to find more information on any stage of the development, manufacturing and approval processes.
This book is ideal for researchers, regulators, academics, project managers, and executives involved in the complex process of combination product development. Not only does it offer a comprehensive guide to the technical aspects of the field, it also integrates all of these technical aspects into a unified, effective approach to help ensure a successful, approved product.
Contents:
Overview of combination products development and regulatory review / Evan B. Siegel
Detailed regulatory approaches to development, review, and approval / James Barquest
Nonclinical recommendations for successful characterization and development of combination drug products / Duane B. Lakings
Clinical pharmacology and clinical development of combination products / Chaline Brown
Regulatory strategy considerations for chemistry, manufacturing, and controls: an integrated approach / Patrick L. DeVillier.
Notes:
Includes bibliographical references and index.
ISBN:
9780470050941
0470050942
OCLC:
190867380

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account